These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15043616)

  • 1. Evidence-based medicine in the dialysis unit: a few lessons from the USRDS and the NCDS and HEMO trials.
    Briggs JP
    Semin Dial; 2004; 17(2):136-41. PubMed ID: 15043616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dialysis outcomes: experimental versus observational evidence.
    Locatelli F; Andrulli S; D'Amico M
    J Nephrol; 2001; 14 Suppl 4():S101-8. PubMed ID: 11798140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short daily and nocturnal hemodialysis: new therapies for a new century?
    Rocco MV
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the hemodialysis dose.
    Leypoldt JK; Cheung AK
    Semin Dial; 2006; 19(2):96-101. PubMed ID: 16551284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care in ESRD.
    Nephrol News Issues; 2003 Feb; 17(3):43-5, 49-50. PubMed ID: 12655998
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of residual kidney function for patients on dialysis: a critical review.
    Perl J; Bargman JM
    Am J Kidney Dis; 2009 Jun; 53(6):1068-81. PubMed ID: 19394737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure].
    Stoffel MP; Lauterbach KW; Baldamus CA
    Z Arztl Fortbild Qualitatssich; 2004 Oct; 98(7):609-16. PubMed ID: 15595603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review.
    Johnson DW; Craven AM; Isbel NM
    Hemodial Int; 2007 Jan; 11(1):1-14. PubMed ID: 17257349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic, quantifiable parameter of dialysis prescription is Kt/V urea; treatment time is determined by the ultrafiltration requirement; all three parameters are of equal importance.
    Gotch F
    Blood Purif; 2007; 25(1):18-26. PubMed ID: 17170532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose of dialysis: key lessons from major observational studies and clinical trials.
    Saran R; Canaud BJ; Depner TA; Keen ML; McCullough KP; Marshall MR; Port FK
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):47-53. PubMed ID: 15486874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized and observational studies in nephrology: how strong is the evidence?
    Greene T
    Am J Kidney Dis; 2009 Mar; 53(3):377-88. PubMed ID: 19185399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurse practitioners and physician assistants in the intensive care unit: an evidence-based review.
    Kleinpell RM; Ely EW; Grabenkort R
    Crit Care Med; 2008 Oct; 36(10):2888-97. PubMed ID: 18766097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency hemodialysis: rationale for randomized clinical trials.
    Kliger AS;
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):390-2. PubMed ID: 17699439
    [No Abstract]   [Full Text] [Related]  

  • 18. NIH seeking applications for short daily, nocturnal dialysis trial.
    Nephrol News Issues; 2003 Feb; 17(3):30-1. PubMed ID: 12655995
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges for randomized controlled trials in nephrology: illustrations in vascular access science and care.
    Lok CE; Moist LM
    J Nephrol; 2007; 20(6):632-45. PubMed ID: 18046665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The political contexts of evidence-based medicine: policymaking for daily hemodialysis.
    Gordon EJ
    Soc Sci Med; 2006 Jun; 62(11):2707-19. PubMed ID: 16376472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.